Patent ID: 6544749
Filing Date: 2003-04-08
Classification: A61K,C07K

Abstract:
An immunoassay comprising the steps of:(a) contacting a test sample with a monoclonal antibody capable of being competitively inhibited in its binding to human Leukemia Inhibitory Factor by a monoclonal antibody selected from the group consisting of mAb D3.14.1, mAb D4.16.9, mAb D25.1.4, and mAb D62.3.2 (American Type Culture Collection Accession Numbers ATCC HB 11076, ATCC HB 11077, ATCC HB 11074, ATCC HB 11075, respectively); and (b) determining the presence of human Leukemia Inhibitory Factor in the test sample.